Disease & disorder

chronic renal failure syndrome

MONDO:0024327

Impairment of the renal function due to chronic kidney damage.

Clinical trials79
Recruiting6
Drug concepts studied14
Synonyms6

Disease research snapshot

CureCurrent currently links 79 distinct registered clinical trials to chronic renal failure syndrome through its MONDO disease mappings. 6 of those studies have the registry status “recruiting” (8%). These are registry statuses, not availability guarantees, study results or evidence of effectiveness.

The leading sponsor shown in this linked dataset is University of Washington, associated with 7 distinct linked trials. This is a count of records, not a ranking of the sponsor's scientific quality.

The highest-count mapped research city in the current result is Seattle, United States. Only site locations available in the published registry projection are counted; some trial sites may be missing or outdated.

The most frequently mapped drug concept in the current linked trials is cinacalcet (1 distinct trials). This describes what has been studied, not a recommended treatment.

Numbers are derived from CureCurrent's current ClinicalTrials.gov projection and conservative MONDO/RxNorm mappings. See sources, counting rules and limitations and verify eligibility or clinical findings with the original study record.

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

Chronic kidney disease

Chronic kidney disease (CKD) is a type of long-term kidney disease, defined by the sustained presence of abnormal kidney function and/or abnormal kidney structure. To meet the criteria for CKD, the abnormalities must be present for at least three months. Early in the course of CKD, patients are usually asymptomatic, but can be diagnosed via proteinuria. At later stages, the symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion. Complications can relate to hormonal dysfunction of the kidneys and include high blood pressure (often related to activation of the renin–angiotensin system), insulin resistance, bone disease, and anemia. Additionally CKD patients have markedly increased cardiovascular complications with increased risks of death and hospitalization. CKD can lead to end-stage kidney failure requiring kidney dialysis or kidney transplantation. Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of chronic kidney disease. Diagnosis is by blood tests to measure the estimated glomerular filtration rate (eGFR), and a urine test to measure albumin. Ultrasound or kidney biopsy may be performed to determine the underlying cause. Several severity-based staging systems are in use. Testing people with risk factors (case-finding) is recommended. Initial treatments may include medications to lower blood pressure, blood sugar, and cholesterol. Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin II receptor antagonists (ARB...

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis PatientsNCT06903559 · 2025-04-15
RECRUITING
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseaseNCT06217302 · 2024-10-31
RECRUITING
Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney DiseaseNCT05283512 · 2022-04-20
RECRUITING
Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal FailureNCT05353946 · 2019-02-02
RECRUITING
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)NCT01802034 · 2013-02-01
RECRUITING
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in ChildrenNCT01604395 · 2012-01-01
RECRUITING
Implementation Trial In patieNts With rEnal failuRe and diAbetes for Major Adverse reNal and Cardiovascular EventsNCT07634718 · 2026-06-01
NOT_YET_RECRUITING
French AKI Registry (FAKIR): A Multicenter Study on the In-Hospital Management and Outcomes of Severe Acute Kidney Injury in Nephrology UnitsNCT07123324 · 2025-11-01
NOT_YET_RECRUITING
Empagliflozin in ESKD - A Feasibility StudyNCT05687058 · 2023-11-01
ACTIVE_NOT_RECRUITING
Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative CareNCT05407272 · 2021-09-14
COMPLETED
HOLT-ED: Holter-monitoring in End-stage Renal DiseaseNCT04876963 · 2021-09-01
COMPLETED
Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)NCT04283994 · 2021-07-26
COMPLETED
Autonomic Nervous System Dysfunction in Patients With End-stage Kidney DiseaseNCT05278702 · 2021-04-01
UNKNOWN
Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in ChildrenNCT04654507 · 2021-03-03
UNKNOWN
Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary DiseasesNCT06909968 · 2020-12-14
COMPLETED
Symbiotics and Systemic Inflammation in Chronic Kidney DiseaseNCT04769687 · 2020-11-21
UNKNOWN
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)NCT04281784 · 2020-04-23
COMPLETED
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)NCT04361552 · 2020-04-07
WITHDRAWN
Exercise for Chronic Kidney DiseasesNCT04522115 · 2020-01-05
COMPLETED
Facilitating Communication StudyNCT03721952 · 2019-04-17
COMPLETED
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot PhaseNCT03791580 · 2019-02-01
WITHDRAWN
Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening ToolNCT04143230 · 2017-05-23
COMPLETED
Hypoxemia in Maintenance Hemodialysis PatientsNCT03045796 · 2017-03-01
UNKNOWN
An Innovative Virtually Supervised Exercise for Dialysis PatientsNCT03076528 · 2016-11-06
COMPLETED
Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.NCT03015909 · 2016-08-11
COMPLETED
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis CentersNCT02823600 · 2016-07-01
COMPLETED
Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant HypertensionNCT02653222 · 2016-02-01
TERMINATED
Low Sodium Dialysate and Ambulatory Blood Pressure Measurement ParametersNCT02621450 · 2015-12-01
UNKNOWN
The Effect of Liraglutide in Patients With Prediabetes and Kidney FailureNCT02284230 · 2014-12-01
WITHDRAWN
Sodium Chloride and Contrast NephropathyNCT03476460 · 2014-04-01
COMPLETED
Improving Communication About Serious IllnessNCT01933789 · 2013-09-01
COMPLETED
Quantification of Drugs and Their Degradation ProductsNCT01828372 · 2013-05-01
UNKNOWN
Chronic Kidney Disease in Teenagers With Congenital Cardiac DiseaseNCT01845402 · 2013-04-02
COMPLETED
Lung Water by Ultrasound Guided Treatment in Hemodialysis Patients (The Lust Study).NCT02310061 · 2013-03-01
COMPLETED
Efficacy and Safety of Alprostadil Prevent Contrast Induced NephropathyNCT01722513 · 2012-11-01
UNKNOWN
Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 DiabetesNCT01617824 · 2012-09-01
COMPLETED
Renal Toxicity of Iodixanol and Iopromide in Patients With Renal DysfunctionNCT01580046 · 2012-04-01
UNKNOWN
Karolinska Cardiorenal Theme-centre and StockholmHeartbankNCT01204645 · 2010-05-01
UNKNOWN
Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)NCT01103336 · 2010-03-01
COMPLETED
Effects of Home-based or Center-based Aerobic Exercise in Patients With Chronic Kidney DiseaseNCT02379533 · 2009-08-01
COMPLETED

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.